Paasa Logo
Shandong Weigao Group Medical Polymer Company Limited logo
1066HKSEMarket closedOpens 9:30am HKT

Shandong Weigao Group Medical Polymer Company Limited

HK$3.20Last updated
-HK$0.06 (1.84%)Past day
Timezone

Shandong Weigao Group Medical Polymer Company Limited (HKSE: 1066) is trading at HK$3.20, about ₹39 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 1.84% today. Indian residents can buy Shandong Weigao Group Medical Polymer from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:HK$3.40
Previous close:HK$3.26
Volume:2.34M

Today's low

HK$3.15

Today's high

HK$3.40

52 week low

HK$2.92

52 week high

HK$6.30

1066 opened at HK$3.40, closed previously at HK$3.26, and has traded between HK$2.92 and HK$6.30 over the past 52 weeks.

About

Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The company structures its extensive operations into several core divisions, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other specialized segments. Its comprehensive product range covers a vast array of essential healthcare items. This includes devices for both vascular and non-vascular access, such as infusion sets, syringes, and specialized puncture needles, alongside various clinical collection kits. Shandong Weigao also provides solutions for wound care, offering sutures, healing dressings, cleaning products, and support devices for non-vascular catheters. In the realm of blood management, it supplies equipment for collection, storage, separation, and sterilization. The company is also a manufacturer of prefilled and pre-flush syringes, as well as instruments for blood collection and glucose monitoring. Its portfolio further extends to anesthesia consumables (general, local, and auxiliary), intensive care unit (ICU) equipment, and tools for both open and minimally invasive surgical procedures. Beyond disposables, the firm is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, and advanced medical components such as implantation materials and artificial organs. It also ventures into industrial manufacturing, producing medical-grade PVC granules, various plastic packaging materials, carton boxes, automated industrial equipment and parts, molds, and hemodialysis machines, encompassing Type I, Type II, and Type III medical devices. In addition to its manufacturing activities, Shandong Weigao offers a range of supporting services. These include finance leasing and factoring, wholesale distribution of Type I, surgical, and other disposable medical products. The company also provides asset management, enterprise consulting, management advisory, and comprehensive logistics and storage solutions, while actively exporting its products to international markets. Operating under recognized brands like Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, the company serves a diverse clientele that includes hospitals, blood banks, various other medical facilities, and a broad network of distributors.

Country
CN
CEO
Rinan Cong
Exchange listed on
HKSE
Industry
Medical - Instruments & Supplies
Base currency
HKD
Full Time Employees
13,310
Sector
Healthcare
IPO date
27/02/2004

Key statistics

Avg. volume

21.97M

Market cap

HK$14.20B

P/E Ratio

9.10

Price-to-sales ratio

0.90

Enterprise value

CN¥9.30B

Free cash flow yield

8.88%

Debt-to-equity ratio

0.20

Return on equity

5.64%

ROIC

4.20%

Beta

0.36

Dividend yield

5.47%

Last dividend

HK$0.17

Financial overview

Revenue

CN¥13.39B

Earnings per share

CN¥0.35

Free cash flow

CN¥1.72B

Net profit margin

10.13%

Gross margin

45.56%

EBITDA

CN¥2.75B

Revenue growth

2.31%

Similar securities

This is not an investment recommendation

How to buy Shandong Weigao Group Medical Polymer from India

Indian residents can buy Shandong Weigao Group Medical Polymer shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.

  3. Search for Shandong Weigao Group Medical Polymer and place an order

    Find Shandong Weigao Group Medical Polymer by name or by its ticker, 1066, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Shandong Weigao Group Medical Polymer trades 7:00 am – 1:30 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Shandong Weigao Group Medical Polymer position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Shandong Weigao Group Medical Polymer from India

Trading and taxes when buying Shandong Weigao Group Medical Polymer from India

Trading and limits

Trading hours
9:30 am – 4:00 pm HKT
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Shandong Weigao Group Medical Polymer’s current yield is 5.47%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Shandong Weigao Group Medical Polymer stock?

Yes. Shandong Weigao Group Medical Polymer (1066) has been listed on the Hong Kong Stock Exchange since 2004, in the Medical - Instruments & Supplies industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Shandong Weigao Group Medical Polymer share cost in rupees?

One Shandong Weigao Group Medical Polymer share is HK$3.20 — about ₹39 at an HKD/INR rate of 12.23 on 26 Sep 2026. Both the Shandong Weigao Group Medical Polymer price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Shandong Weigao Group Medical Polymer from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Shandong Weigao Group Medical Polymer?

Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

How are gains on Shandong Weigao Group Medical Polymer shares taxed in India?

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shandong Weigao Group Medical Polymer price. Paasa issues a capital-gains statement for your return.

Does Shandong Weigao Group Medical Polymer pay a dividend, and how is it taxed in India?

Yes. Shandong Weigao Group Medical Polymer pays a dividend and the current yield is 5.47%; the last declared dividend was HK$0.17 per share, about ₹2.14. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Shandong Weigao Group Medical Polymer from India?

The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.

Is Shandong Weigao Group Medical Polymer a Hong Kong SAR China company, and does that change how it is taxed?

Shandong Weigao Group Medical Polymer trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Shandong Weigao Group Medical Polymer trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Shandong Weigao Group Medical Polymer shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Shandong Weigao Group Medical Polymer holding, its cost and its closing value.

How do I sell Shandong Weigao Group Medical Polymer and bring the money back to India?

You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.